Characterization of Physicians That Might Be Reluctant to Propose HIV Cure-Related Clinical Trials with Treatment Interruption to Their Patients? The ANRS-APSEC Study

HIV cure-related clinical trials (HCRCT) with analytical antiretroviral treatment interruptions (ATIs) have become unavoidable. However, the limited benefits for participants and the risk of HIV transmission during ATI might negatively impact physicians’ motivations to propose HCRCT to patients. Bet...

Descripción completa

Detalles Bibliográficos
Autores principales: Protiere, Christel, Fressard, Lisa, Mora, Marion, Meyer, Laurence, Préau, Marie, Suzan-Monti, Marie, Lelièvre, Jean-Daniel, Lambotte, Olivier, Spire, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350235/
https://www.ncbi.nlm.nih.gov/pubmed/32585921
http://dx.doi.org/10.3390/vaccines8020334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350235/
https://www.ncbi.nlm.nih.gov/pubmed/32585921
http://dx.doi.org/10.3390/vaccines8020334

Ejemplares similares